Compare MCK & LMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MCK | LMT |
|---|---|---|
| Founded | 1833 | 1912 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Other Pharmaceuticals | Military/Government/Technical |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 107.4B | 105.1B |
| IPO Year | N/A | N/A |
| Metric | MCK | LMT |
|---|---|---|
| Price | $814.96 | $479.05 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 13 | 15 |
| Target Price | ★ $882.69 | $517.87 |
| AVG Volume (30 Days) | 848.8K | ★ 1.4M |
| Earning Date | 11-05-2025 | 01-27-2026 |
| Dividend Yield | 0.40% | ★ 2.87% |
| EPS Growth | ★ 66.19 | N/A |
| EPS | ★ 32.12 | 17.88 |
| Revenue | ★ $387,094,000,000.00 | $73,349,000,000.00 |
| Revenue This Year | $14.87 | $6.01 |
| Revenue Next Year | $8.32 | $4.23 |
| P/E Ratio | ★ $25.34 | $26.86 |
| Revenue Growth | ★ 17.23 | 2.88 |
| 52 Week Low | $558.13 | $410.11 |
| 52 Week High | $895.58 | $516.00 |
| Indicator | MCK | LMT |
|---|---|---|
| Relative Strength Index (RSI) | 44.67 | 61.77 |
| Support Level | $793.92 | $455.88 |
| Resistance Level | $818.92 | $457.26 |
| Average True Range (ATR) | 17.31 | 8.90 |
| MACD | -6.82 | 4.10 |
| Stochastic Oscillator | 21.63 | 97.80 |
McKesson Corp is one of three leading pharmaceutical wholesalers in the US engaged in sourcing and distributing branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with Cencora and Cardinal Health, the three account for over 90% of the US pharmaceutical wholesale industry. Outside the US market, McKesson engages in pharmaceutical wholesale and distribution in Canada. Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.
Lockheed Martin is the world's largest defense contractor and has dominated the Western market for high-end fighter aircraft since it won the F-35 Joint Strike Fighter program in 2001. Aeronautics is Lockheed's largest segment, which derives upward of two-thirds of its revenue from the F-35. Lockheed's remaining segments are rotary and mission systems, mainly encompassing the Sikorsky helicopter business; missiles and fire control, which creates missiles and missile defense systems; and space systems, which produces satellites and receives equity income from the United Launch Alliance joint venture.